Indeed, in various cancers, increased YAP/TAZ levels have been observed because of mutations in MST1/2 and LATS1/2 as well as gene amplification of YAP1 and WWTR1, which encode YAP and TAZ [14–21]. Here, YAP1 is linked to cancer.